Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test

References

• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):1–11. doi: 10.1097/CM9.0000000000002108.
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020;158(2):291–302. doi: 10.1053/j.gastro.2019.08.059.
   PubMed Web of Science ®Google Scholar
• Liang PS, Dominitz JA. Colorectal cancer screening: is colonoscopy the best option? Med Clin North Am. 2019;103(1):111–123. doi: 10.1016/j.mcna.2018.08.010.
   PubMed Web of Science ®Google Scholar
• Pooler BD, Kim DH, Matkowskyj KA, et al. Growth rates and histopathological outcomes of small (6–9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal. Gut. 2023;28:gutjnl-2022-326970. doi: 10.1136/gutjnl-2022-326970.
   Google Scholar
• Bitler MP, Carpenter CS, Horn D. Effects of the colorectal cancer control program. Health Econ. 2021;30(11):2667–2685. doi: 10.1002/hec.4397.
   PubMed Web of Science ®Google Scholar
• Chen H, Li N, Ren J, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut. 2019;68(8):1450–1457. doi: 10.1136/gutjnl-2018-317124.
   PubMed Web of Science ®Google Scholar
• Fears CY, Gladson CL, Woods A. Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J Biol Chem. 2006;281(21):14533–14536. doi: 10.1074/jbc.C600075200.
   PubMed Web of Science ®Google Scholar
• Zhao G, Ma Y, Li H, et al. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2. Clin Chim Acta. 2020;503:84–89. doi: 10.1016/j.cca.2020.01.010.
   PubMed Web of Science ®Google Scholar
• Carethers JM. Fecal DNA testing for colorectal cancer screening. Annu Rev Med. 2020;71(1):59–69. doi: 10.1146/annurev-med-103018-123125.
   PubMed Web of Science ®Google Scholar
• Expert consensus opinion on early colorectal cancer screening process in China (2019, Shanghai). Zhong Hua Xiao Hua Nei Jing Za Zhi. 2019;36(10):709–719.
   Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287–1297. doi: 10.1056/NEJMoa1311194.
   PubMed Web of Science ®Google Scholar
• Eckmann JD, Ebner DW, Bering J, et al. Multitarget stool DNA screening in clinical practice: high positive predictive value for colorectal neoplasia regardless of exposure to previous colonoscopy. Am J Gastroenterol. 2020;115(4):608–615. doi: 10.14309/ajg.0000000000000546.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(3):329–359. doi: 10.6004/jnccn.2021.0012.
   PubMed Web of Science ®Google Scholar
• Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018;67(2):291–298. doi: 10.1136/gutjnl-2016-312712.
   PubMed Web of Science ®Google Scholar
• Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clinicians. 2014;64(2):104–117. doi: 10.3322/caac.21220.
   PubMed Web of Science ®Google Scholar
• Chen HD, Li N, Ren JS, et al. Compliance and related factors of colonoscopy screening among high-risk colorectal cancer population in urban China. Zhong Hua Yu Fang Yi Xue Za Zhi. 2018;52(03):231–237.
   PubMedGoogle Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Kolligs FT, Crispin A, Munte A, et al. Risk of advanced colorectal neoplasia according to age and gender. PLoS One. 2011;6(5):e20076. doi: 10.1371/journal.pone.0020076.
   PubMed Web of Science ®Google Scholar
• Konstantinopoulos PA, Kominea A, Vandoros G, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in Colon adenocarcinoma paralleling the tumour’s dedifferentiation. Eur J Cancer. 2003;39(9):1251–1258. doi: 10.1016/S0959-8049(03)00239-9.
   PubMed Web of Science ®Google Scholar
• Viani L, Abate PD, Rio PD, et al. Colorectal cancer screenings: a single center experience. Acta Biomed. 2020;91(4):1–5.
   Google Scholar
• Sievers CK, Zou LS, Pickhardt PJ, et al. Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates. Gut. 2017;66(12):2132–2140. doi: 10.1136/gutjnl-2016-312232.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu S, Wang H, et al. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study. Clin Epigenet. 2020;12(1):162. doi: 10.1186/s13148-020-00954-x.
   PubMed Web of Science ®Google Scholar
• Niu F, Wen J, Fu X, et al. Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1411–1419. doi: 10.1158/1055-9965.EPI-17-0153.
   PubMed Web of Science ®Google Scholar
• Carethers JM, Jung BH. Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology. 2015;149(5):1177–1190.e3. doi: 10.1053/j.gastro.2015.06.047.
   PubMed Web of Science ®Google Scholar
• Oines M, Helsingen LM, Bretthauer M, et al. Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol. 2017;31(4):419–424. doi: 10.1016/j.bpg.2017.06.004.
   PubMed Web of Science ®Google Scholar